These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30239388)

  • 1. We all need support but can our patients help us to help them?
    Dalley C
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):516-517. PubMed ID: 30239388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Childhood cancer surviving].
    Tabone MD; Sommelet D
    Arch Pediatr; 2006 Jun; 13(6):607-9. PubMed ID: 16690270
    [No Abstract]   [Full Text] [Related]  

  • 3. Anorexia and weight loss in long-term survivors of haematological malignancies.
    Molassiotis A
    J Clin Nurs; 2003 Nov; 12(6):925-7. PubMed ID: 14632985
    [No Abstract]   [Full Text] [Related]  

  • 4. Supportive care.
    Ludwig H; Zojer N
    Ann Oncol; 2007 Jan; 18 Suppl 1():i37-i44. PubMed ID: 17311821
    [No Abstract]   [Full Text] [Related]  

  • 5. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?
    Efficace F; Novik A; Vignetti M; Mandelli F; Cleeland CS
    Haematologica; 2007 Dec; 92(12):1596-8. PubMed ID: 18055981
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of hematological malignancies in the elderly].
    Ohta M
    Rinsho Ketsueki; 2008 Jun; 49(6):382-9. PubMed ID: 18646605
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating hematologic malignancies: barriers to care.
    Shonkwiler E
    ONS News; 2006; 21(8 Suppl):23-4. PubMed ID: 16925137
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers to Quality End-of-Life Care for Patients With Blood Cancers.
    Odejide OO; Cronin AM; Condron NB; Fletcher SA; Earle CC; Tulsky JA; Abel GA
    J Clin Oncol; 2016 Sep; 34(26):3126-32. PubMed ID: 27400944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons.
    Bryant J; Sanson-Fisher R; Stevenson W; Smits R; Henskens F; Wei A; Tzelepis F; D'Este C; Paul C; Carey M
    BMC Cancer; 2015 Apr; 15():295. PubMed ID: 25886517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life among patients with hematological cancer in a Malaysian hospital.
    Priscilla D; Hamidin A; Azhar MZ; Noorjan KO; Salmiah MS; Bahariah K
    Med J Malaysia; 2011 Jun; 66(2):117-20. PubMed ID: 22106690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peer and romantic relationships among adolescent and young adult survivors of childhood hematological cancer: a review of challenges and positive outcomes.
    Foster RH; Stern M
    Acta Haematol; 2014; 132(3-4):375-82. PubMed ID: 25228563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory chemotherapy in hematology. A challenge ...].
    Montagne C; Duran B
    Soins; 1996 Sep; (608):62-8. PubMed ID: 8954491
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies.
    Opsomer MA; Anota A; Noblot-Rossignol M; Bonnetain F; Pernot C; Chretien ML; Legouge C; Caillot D; Boulin M
    Ann Pharm Fr; 2016 Nov; 74(6):439-447. PubMed ID: 27162122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensive care support of patients with malignancy: do everything that can be done.
    Azoulay E; Afessa B
    Intensive Care Med; 2006 Jan; 32(1):3-5. PubMed ID: 16308682
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients treated for hematologic malignancies: affected sexuality and health-related quality of life.
    Olsson C; Sandin-Bojö AK; Bjuresäter K; Larsson M
    Cancer Nurs; 2015; 38(2):99-110. PubMed ID: 25692735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative care for patients with hematological malignancies--if not, why not?
    McGrath P
    J Palliat Care; 1999; 15(3):24-30. PubMed ID: 10540795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials].
    Graf N; Göbel U
    Klin Padiatr; 2004; 216(3):129-31. PubMed ID: 15175956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Traceability of oncohematological drugs through data capture codes].
    Escudero-Vilaplana B; Manso-Manrique M; García-Sanz E; Sánchez-Guerrero A
    Farm Hosp; 2017 Sep; 41(5):649-650. PubMed ID: 28847260
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics: Difficult Decisions.
    Deeg HJ; Steuten LM
    JAMA Oncol; 2015 Aug; 1(5):571-2. PubMed ID: 26181003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.